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948Objective: Prolonged alveolar air leak (PAAL) is a frequent occurrence after lobectomy or lesser resections. The
resulting complications and their impact are not well understood. Our aims are to prospectively determine the
incidence and severity of PAAL after pulmonary resection using the Thoracic Morbidity & Mortality classifi-
cation system and to identify risk factors.
Methods: A prospective collection of Thoracic Morbidity & Mortality data was performed for all consecutive
pulmonary resections (n ¼ 380; January 2008 to April 2010). Demographics, comorbidities, and preoperative
cardiopulmonary assessment were retrospectively identified. The incidence and severity (grades I-V) of burden
from PAAL were quantified using the Ottawa Thoracic Morbidity & Mortality system. Risk factors for PAAL
and severe PAAL (defined as leading to major intervention, organ failure, or death) were sought with univariate
and multivariate analyses.
Results: The incidences of PAAL and severe PAAL were 18% and 4.8%, respectively. PAAL prolonged
the median hospital stay by 4 days. The majority of complications associated with PAAL were limited to
pulmonary and pleural categories (90%). Significant predictors of PAAL from multivariate analysis include
severe radiologic emphysema (odds ratio [OR], 2.8; confidence interval [CI], 1.2-6.2), histopathologic
emphysema (OR, 1.9; CI, 1.1-3.6), percentage of predicted value for forced expiratory volume in 1 second
less than 80% (OR, 1.9; CI, 1.1-3.3), and lobectomy (OR, 4.9; CI, 1.-14.1). Risk factors for severe PAAL
include radiologic emphysema, percentage of predicted value for forced expiratory volume in 1 second less
than 80%, forced expiratory volume in 1 second/forced vital capacity ratio less than 70%, and intraoperative
difficulties (P<.05).
Conclusions: PAAL leads to longer hospital stays, and approximately 4.8% of patients undergoing pulmonary
resection experience PAAL that necessitates placement of additional chest drains, bronchoscopy, reoperation, or
life support. Further study is required to assess the cost-effectiveness of measures to reduce PAAL. (J Thorac
Cardiovasc Surg 2013;145:948-54)Earn CME credits at
http://cme.ctsnetjournals.org
Prolonged alveolar air leak (PAAL) is the most common
complication and reason for increased hospital length of
stay (LOS) after elective lobectomy or lesser lung resec-
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The Journal of Thoracic and Cardiovascular Surgthan 3 to 7 days,3-6 and its incidence ranges from 8% to
26%.3-5,7-9 Given the important clinical impact of PAAL,
attempts to delineate specific risk factors for PAAL have
been reported in previous series with variable consistency.
The most consistent risk factor is chronic obstructive
pulmonary disease, reflected by preoperative pulmonary
function test (PFT): forced expiratory volume in 1 second
(FEV1)/forced vital capacity (FVC) ratio less than 70%,
FEV1 less than 1.5 liters, FEV1 less than 79% predicted,
and diffusing capacity of carbon monoxide (DLCO) less
than 80% predicted.3-9 Other potential risk factors,
including radiologic and pathologic findings of chronic
obstructive pulmonary disease, have not been studied.
The impact that PAALhas onpatient recovery andhospital
resources is significant. It increases LOS by 5 to 13 days2,10
and leads to additional complications in both the lung and the
pleural space, such as atelectasis, pneumonia, empyema, and
prolonged need for chest drains.3,11 There has been some
difficulty in quantifying what constitutes severe PAAL. As
a result, the incidence, predictors, and burden of illness
from severe PAAL remain elusive.ery c April 2013
Abbreviations and Acronyms
CI ¼ confidence interval
CT ¼ computed tomography
DLCO ¼ diffusing capacity of carbon monoxide
%DLCO ¼ percentage of predicted values
for DLCO for age, gender, and height
FEV1 ¼ forced expiratory volume in 1 second
%FEV1 ¼ percentage of predicted value for FEV1
FVC ¼ forced vital capacity
LOS ¼ length of stay
OR ¼ odds ratio
PAAL ¼ prolonged alveolar air leak
PFT ¼ pulmonary function test
POD ¼ postoperative day
TM&M ¼ Thoracic Morbidity & Mortality
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SThe current study addresses the issues of stratification
of burden of illness by using an adverse event monitoring
and reporting system, the Ottawa Thoracic Morbidity &
Mortality (TM&M) system. The TM&M system is de-
rived from the Clavien-Dindo classification,12-14 which
classifies the severity of a complication on the basis of
the impact it has on the patient, namely, a complication
that occurs leading to no change in management (I),
new medical therapy (II), major intervention (III), organ
failure (IV), or death (V). We developed definitions of
thoracic complications listed by system and stratified by
severity.12,13 Furthermore, the origin and classification
of each complication were reviewed and discussed
weekly over several years, helping to refine the TM&M
system. In the current study, the primary outcomes of
interest include rates of nonsevere (grades I-II) and
severe PAAL (grades III-V). Secondary outcomes include
the presence of additional adverse events, LOS, and rates
of readmissions in patients with PAAL.MATERIALS AND METHODS
Patients
The data for 380 consecutive pulmonary resections for malignant and
benign disease within the Ottawa Hospital from January 2008 to May
2010 were prospectively collected by the Ottawa Hospital Division of Tho-
racic Surgery, approved by the Ottawa Hospital Research Ethics Board.
The funding agency had no role in designing the study, analyzing the
data, writing the report, or making the decision to submit the manuscript
for publication. Prospective TM&M data were initially recorded by the
chief resident, reviewed weekly by thoracic staff surgeons, and presented
monthly at morbidity and mortality rounds. Patients with pancoast tumors
(n ¼ 0), patients with tumors requiring pneumonectomy (n ¼ 24), or pa-
tients who did not have any preoperative evaluations before surgery on re-
cord (n ¼ 4) were excluded. The records of 352 pulmonary resections
remained for analysis. Four patients had 2 separate pulmonary resections
during the study period. The data for each surgery were considered as an
independent entry in the analysis.The Journal of Thoracic and CaCollection of Preoperative Data
The preoperative evaluations included complete history, physical exam-
ination, PFT, arterial blood gas, computed tomography (CT) scan of the
chest, echocardiography or cardiac stress tests, and biopsy. The severity
of emphysema was graded by a chest radiologist and recorded in the radio-
logic reports. Operative, radiologic, and pathology reports and the TM&M
database were reviewed to document the procedure, intraoperative compli-
cations, and pathologic stage. Data were collected on paper case report
forms and entered into a Microsoft Excel computer database (Microsoft
Corp, Redmond, Wash).
Intraoperative and Postoperative Collection
of Prolonged Alveolar Air Leak and Thoracic
Morbidity & Mortality Data
The techniques of pulmonary resection, chest tube placement, and man-
agement were not controlled; however, general principles guided surgical
intraoperative and postoperative practice. Mechanical staplers were mostly
used to complete incomplete fissures; however, in open cases, cautery often
was used to develop fissures overlying the pulmonary artery. All bronchial
stumps were verified to be airtight before closure. If vigorous air leaks were
identified intraoperatively, the parenchymal source of bubbling was re-
paired with sutures. In general, patients who underwent lobectomy re-
ceived two 28F chest tubes or one 28F chest tube and one 14F pigtail
pleural catheter. Those patients who underwent segmentectomy or wedge
resection received one 28F chest tube. Immediately after the surgery, the
chest tubes were attached to the Sahara S-11000 (Teleflex, Research Trian-
gle Plus, Durham, NC) analogue chest drainage system and placed on10
to20 cmH2O suction. The tubes were converted towater seal on themorn-
ing of postoperative day (POD) 1 after chest radiography. The forced expi-
ratory air leak was determined by visualizing bubbles in the analogue
drainage system while the patient coughed in an upright sitting position.
Patients remained on water seal unless they had an enlarging symptomatic
pneumothorax or subcutaneous emphysema developed. When no air leak
was detected, the chest tube was removed. If the air leak was equivocal,
the tube was clamped and chest radiography was performed, followed by
removal of the chest tube if no new pneumothorax or subcutaneous emphy-
sema was identified. If the patient continued to have an air leak on the day
of discharge, the patient was discharged with the chest tube attached to
a Pneumostat Chest Drain Valve (Atrium Medical Corp, Hudson, NH)
and re-evaluated 5 to 7 days later.
Classification of Postsurgical Complications
In the current study, PAAL is defined as a forced expiratory air leak pres-
ent on POD 5. The 5-day definition also is consistent with that used in the
European Society of Thoracic Surgeons and the American Society of Tho-
racic Surgeons research databases. The presence and severity of postoper-
ative PAAL were classified using the validated Ottawa TM&M,12,13
developed in accordance with the Clavien classification system.14 The
types of complications are pulmonary, pleural, anastomotic, cardiac, renal,
gastric, neurologic, and wound, and there are smaller categories within
each of these categories (not analyzed in the current study). In the context
of PAAL, the complication grade starts at II, which requires a chest tube for
more than 5 days after surgery; and proceeds to grade III, which requires
the insertion of an additional chest tube (grade IIIA) or reoperation (grade
IIIB); grade IV, which requires intensive care and life support; and grade V,
which results in mortality within 30 days. The use of the Pneumostat Chest
Drain Valve (Atrium Medical Corp) by itself was considered a grade II
complication, as long as the patient did not require interventions listed in
the higher grades.
Statistical Analysis
Data were collected as categoric variables and converted to binary nu-
meric data where applicable. Univariate analysis using chi-square testsrdiovascular Surgery c Volume 145, Number 4 949
TABLE 1. Significant risk factors for prolonged alveolar air leak in
the preoperative variables
Patient
characteristics Control, n (%) PAAL, n (%) P value
Bronchitis 12/287 (4.2%) 7/65 (10.8%) .0338*
Smoking status n ¼ 285 n ¼ 65 —
Never 43 (15.1%) 4 (6.2%) .0566
Current 94 (33.0%) 23 (35.4%) .7110
Pack-year 20.2 28.8 .0209*
Past 139 (48.8%) 38 (58.4%) .1585
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tween the control and severe PAAL groups. Variables with a P value less
than .05 in the univariate analysis were used as independent variables in
forward logistic regression analysis. In 46 cases, there were missing values
in PFT values or radiologic grading of emphysema. Therefore, imputa-
tional statistics were used to replace the missing values. Discrimination
and calibration of the model were assessed using the C statistic and the
Hosmer–Lemeshow goodness of fit test. For variables containing multiple
categories, such as procedure performed, a reference category was chosen.
Only variables with a .15 significance level were entered into the final
logistic model. The model satisfied the convergence criteria. Data were
analyzed using SAS version 9.2 (SAS Institute Inc, Cary, NC).
Pack-year 39.0 41.5 .0033y
Diagnosis n ¼ 287 n ¼ 65 —
NSCLC 210 (73.1) 60 (92.3) .0010y
Other malignant 66 (23.0) 3 (4.6) .0007y
Benign 11 (3.8) 2 (3.1) .7705
Emphysema on CT n ¼ 275 n ¼ 63 —
None 203 (73.8%) 32 (50.8%) .0003y
Not severe 50 (18.2%) 18 (28.6%) .0635
Severe 22 (8.0%) 13 (20.6%) .0030y
FEV1 actual 2.21 2.13 .1169
% FEV1 n ¼ 275 n ¼ 58 —
No. of patients 105 (38.2%) 34 (58.6%) .0041yRESULTS
Study Population Demographics
A total of 352 pulmonary resections met the inclusion cri-
teria: 13 resections for benign disease and 339 resections for
malignant disease (270 non–small cell lung cancers and 63
other malignancies). There was no significant difference
between study groups regarding age more than 70 years
(P ¼ .12), male sex (P ¼ .25), and body mass index
greater than 25 kg/m2 (P ¼ .31).<70%
Numeric value Mean 85.3, SE 1.2 Mean 78.9, SE 2.6 .029*
FEV1/FVC n ¼ 271 n ¼ 59 —
No. of patients
<80%
124 (45.8%) 38 (64.4%) .0094y
Numeric value Mean 68.8, SE 0.58 Mean 64.2, SE 1.5 .005y
Lobectomy 193/287 (67.2%) 60/65 (92.3%) <.0001y
Right upper 58/193 (30.1%) 33/60 (55%) .0004y
Right middle 17/193 (8.8%) 1/60 (1.7%) .0602
Right lower 31/193 (16.1%) 9/60 (15.0%) .8439
Left upper 50/193 (25.9%) 15/60 (25.0%) .8883
Left lower 37/193 (19.2%) 2/60 (3.3%) .0030y
Wedge resection 171/216 (88.6%) 30/54 (46.2%) .0004y
Lobectomyþwedge 92/287 (32.1%) 25/64 (38.5%) .2823
Lobectomy alone 38/287 (13.2%) 24/65 (36.9%) <.0001y
Wedge alone 79/287 (27.5%) 4/65 (6.2%) .0002y
Bilobectomy 2/291 (0.7%) 0/65 (0%) .5027
Extended lobectomy 3/287 (1.0%) 3/65 (4.6%) .0447*
Segmental resection 16/287 (5.6%) 1/65 (1.5%) .1705
Pleural adhesions 76/286 (26.5%) 26/65 (40.0%) .0314*
Emphysema on path 127/287 (44.3%) 44/64 (67.7%) .0006y
Statistically significant risk factors for PAAL from univariate analysis. Results are ex-
pressed as count/total population of the collected data, followed by percentage of total
of the group in brackets, except in rows with continuous variable statistics. Lung can-
cers are staged according to American Joint Committee on Cancer 7th edition. PAAL,
Prolonged alveolar air leak; NSCLC, non–small cell lung cancer; CT, computed
tomography; FEV1, forced expiratory volume in 1 second; %FEV1, percentage
of predicted value for FEV1; FVC, forced vital capacity; SE, standard error. *P<.05.
yP<.01.Univariate and Multivariate Analyses to Identify
Risk Factors Associated With Prolonged Alveolar
Air Leak
The incidence of PAAL was 18% (n ¼ 65). Table 1 lists
the significant preoperative and intraoperative risk factors
analyzed in this study (P<.05). The PAAL group had higher
pack-years of smoking (41.5 vs 38.5 pack-years) and self-
reported diagnosis of bronchitis (10.8% vs 4.2%). Patients
with PAAL were more likely to have undergone pulmonary
resections for non–small cell lung cancers (92.3% vs
73.1%), to display severe emphysema on CT scan (20.6%
vs 8.0%) and on histopathology (67.7% vs 44.3%), and to
have an obstructive pattern on PFT (predicted FEV1
<80%: 58.6% PAAL vs 38.2% control; FEV1/FVC
<70%: 64.4% PAAL vs 45.8% control). An additional
t test for PFT items showed that patients with PAAL have
a significantly lower percentage of predicted value for
FEV1 (%FEV1) and FEV1/FVC ratio (P< .05), but there
was no difference in percentage of predicted values for
DLCO for age, gender, and height (%DLCO). Patients
with PAAL were more likely to have undergone lobectomy
(92.3% of PAAL cases vs 67.2% of control cases) and
have pleural adhesions requiring lysis or decortication
(40.4% vs 26.5%). There was no difference in the rate of
PAAL between minimally invasive or open approaches
(P¼ .83). Other nonsignificant variables from the univariate
analyses include history of coronary artery disease (P¼ .34),
asthma (P ¼ .15), pulmonary hypertension (P ¼ .26), lung
cancer stage (P¼ .20), chemotherapy (P¼ .28), radiotherapy
(P ¼ .63), percent of residual volume (P ¼ .32), %DLCO
(P ¼ .88), intraoperative complications (P ¼ .58), and atel-
ectasis on POD 1 (P ¼ .18).950 The Journal of Thoracic and Cardiovascular SurgThe results of the multivariate analysis are shown in
Table 2. For the purpose of multivariate analysis, the
category ‘‘procedure performed’’ was reclassified into 3
subcategories: wedge, segmental resection, and lobectomy.
Lobectomy includes all the different lobes resected and ex-
tended lobectomies. Significant predictors of PAAL areery c April 2013
TABLE 2. Results of multivariate analysis of risk factors for
prolonged alveolar air leak
Variable P value
Point estimate
of OR 95% CI
Radiologic emphysema .035*
None (reference)
Not severe .15 1.7 0.83-3.3
Severe .014* 2.8* 1.2-6.2
Pathologic emphysema .032* 1.9* 1.1-3.6
Bronchitis .058* 2.9 0.97-8.5
%FEV1 .035*
80 (reference)
80 .035* 1.9* 1.1-3.3
Procedure performed .0097y
Wedge (reference)
Segmental resection .72 1.52 0.15-15.4
Lobectomy .0038y 4.8* 1.7-14.1
The final model has a C statistic value of 0.74, Hosmer–Lemeshow chi-square of 4.1,
and P¼ .77.OR, Odds ratio;CI, confidence interval;%FEV1, percentage of predicted
value for FEV1. Results of multivariate analysis on risk factors for PAAL. *P<.05.
yP<.01.
TABLE 3. Risk factors for severe prolonged alveolar air leak
Control (%) Severe PAAL (%) P value
Smoking status n ¼ 278 n ¼ 17 —
Never 44 (15.8%) 2 (11.8%) .6540
Current 95 (34.2%) 6 (35.3%) .9246
Past 139 (50.0%) 9 (52.9%) .8139
Abnormal right
echocardiogram
5/225 (2.2%) 2/16 (12.5%) .0180*
Emphysema on path 127/287 (44.3%) 10/17 (58.8%) .2404
Emphysema on CT n ¼ 275 n ¼ 17 —
None 201 (73.1%) 6 (35.3%) .0009y
Not severe 50 (18.2%) 7 (41.2%) .0203*
Severe 22 (8.0%) 4 (23.5%) .0291*
%FEV1 n ¼ 275 n ¼ 14 —
No. of patients
<80%
105 (38.2%) 10 (71.4%) .0132*
Numeric value Mean 85.3, SE 1.2 Mean 70.9, SE 3.7 .002y
FEV1/FVC n ¼ 271 n ¼ 15 —
No. of patients
<70%
124 (45.8%) 12 (80.0%) .0097y
Numeric value Mean 68.8, SE 0.58 Mean 61.1, SE 2.9 .021*
%DLCO n ¼ 255 n ¼ 15 —
No. of patients
<60%
39 (15.3%) 3 (20.0%) .6251
Numeric value Mean 79.3, SE 1.2 Mean 75.0, SE 5.3 .441
Wedge resection 171/216 (79.2%) 7/13 (53.8%) .0331*
Intraoperative
complications
13/287 (4.5%) 3/17 (17.6%) .0186*
The results from univariate analysis on risk factors for severe PAAL. Results are ex-
pressed as numeric value of the count, followed by percentage of total of the group in
brackets except in rows with continuous variable statistics. The total number of col-
lected cases for each category is expressed as n¼ number. PAAL, Prolonged alveolar
air leak; CT, computed tomography; FEV1, forced expiratory volume in 1 second;
%FEV1, percentage of predicted value for FEV1; FVC, forced vital capacity;
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[OR], 2.8; confidence interval [CI], 1.2-6.2), histopatho-
logic finding of emphysema (OR, 1.9; CI, 1.1-3.6),
%FEV1 less than 80% (OR, 1.9; CI, 1.1-3.3), and lobec-
tomy (OR, 4.8; CI, 1.7-14.1). Of note, smoking history,
self-reported history of bronchitis, type of tumor, pleural
adhesions, and FEV1/FVC less than 70% were not signif-
icant predictors of PAAL. The final model had a C statis-
tic of 0.74, Hosmer–Lemeshow chi-square value of 4.1,
and P value of .77.%DLCO, percentage of predicted values for DLCO for age, gender, and height;
SE, standard error. *P<.05. yP<.01.
Univariate Analysis to Identify Risk Factors
AssociatedWith Severe Prolonged Alveolar Air Leak
The incidence of severe PAAL was 4.8% among all
patients and 26% in the PAAL group. Risk factors for
severe PAAL are shown in Table 3. Significant risk fac-
tors (P<.05) included abnormal right ventricular func-
tion seen on echocardiogram (12.5% severe PAAL vs
2.2% control), radiologic finding of emphysema on CT
scan (23.5% vs 8.0%), FEV1 less than 80% predicted
(71.4% vs 38.2%), FEV1/FVC less than 70 (80% vs
45.8%), and occurrence of intraoperative difficulties
(17.6% vs 4.5%), such as intraoperative hypoxemia,
bleeding, and hypotension. An additional t test for PFT
items showed that patients with severe PAAL had
significantly lower %FEV1 (P < .01) and FEV1/FVC
ratio (P< .05), but there was no difference in %DLCO.
Patients with severe PAAL were less likely to have under-
gone wedge resection (53.8% severe PAAL vs 79.2%
control). Of note, patients with severe PAAL did not dis-
play a significant difference in smoking history (P ¼ .65)
or pathologic findings of emphysema (P ¼ .24) compared
with the control group.The Journal of Thoracic and CaPostoperative Management of Prolonged Alveolar
Air Leak, Length of Stay, Readmission, and
Additional Complications
LOS was significantly longer in the PAAL group (86.2%
stayed for >5 days) compared with the control group
(29.2%) (P ¼ .001). Likewise, the rate of readmission
within 30 days was 24.6% in patients with PAAL compared
with 4.2% in patients without PAAL. Patients with PAAL
maintained an indwelling chest drain for an average of 18 
16.4 days, and 46.2% of those with PAAL were discharged
with a chest drain. The duration of PAAL is shown in
Table 4. The time course of severe PAAL is significantly
longer than that of nonsevere PAAL.
Patients with PAAL also were found to have a higher av-
erage number of complications in comparison with the con-
trol group (1.26 per patient vs 0.42 per patient, respectively;
P< .05). The breakdown of grades of complications is
shown in Table 5, and the pie charts for grades and types
of complications are shown in Figure 1. PAAL developed
in 65 patients (18.1% of total); 48 patients had nonsevererdiovascular Surgery c Volume 145, Number 4 951
TABLE 4. Time course of nonsevere and severe prolonged alveolar air
leak
Nonsevere
PAAL (%)
Severe
PAAL (%) P value
Duration of PAAL n ¼ 48 n ¼ 17 —
5 d 3 (6.2%) 1 (5.9%) .72
6-10 d 18 (37.5%) 2 (11.7%) .043*
11-30 d 24 (50.0%) 7 (41.2%) .037*
30 d 3 (6.2%) 7 (41.2%) .0020y
The proportion of patients with PAAL of different duration, broken down by nonse-
vere and severe PAAL groups. PAAL, Prolonged alveolar air leak. *P<.05. yP<.01.
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of all patients), and 17 patients had severe PAAL (grade
III, 26.1% of patients with PAAL and 4.6% of all pa-
tients). With grade II PAAL, the patients required discharge
with a chest tube or experienced a prolonged LOS and were
managed with the chest drains placed at the time of pulmo-
nary resection. However, a grade IV complication devel-
oped in 1 patient in the nonsevere PAAL group, not as
a result of PAAL, but as a result of pulmonary embolism,
atelectasis, and pneumonia. Grade IIIA PAAL occurred in
12 patients (18.5% of PAAL, 3.4% of all), who required in-
terventions such as bronchoscopy or insertion of additional
chest drains. Grade IIIB occurred in 3 patients (4.6% of
PAAL, 0.85% of all), who required a reoperation to control
the air leak. Grade IV PAAL occurred in 2 patients (3.1% of
PAAL, 0.57% of all), who were admitted to the intensive
care unit as a result of air leak. There was no mortality
within 30 days of surgery in the PAAL group. The control
group had significantly fewer grade IIIa complications
and pulmonary and pleural complications than the PAAL
group (P < .05). The control group had more cardiac
complications (41.3% control vs 7.3% PAAL, P< .05),
and 40% of these were atrial fibrillation.
Of the 82 complications in the PAAL group, most (90%)
were pulmonary and pleural in nature. The associated com-
plications of severe PAAL (17 patients) included empyemaTABLE 5. Difference in complication rates between groups by
severity
Complication grade Control PAAL P value
Grade I 10 — —
Grade II 86 58 .958
Grade III
Grade IIIA 6 15 .002*
Grade IIIB 5 6 .325
Grade IV
Grade IVA 9 3 .263
Grade IVB 2 0 .5161
Grade V 3 0 .2741
Total no. of complications 121 82 —
Total no. of patients 287 65 —
Numeric counts of complications broken down by the Ottawa TM&M grades in con-
trol and PAAL groups. PAAL, Prolonged alveolar air leak. *P<.01.
952 The Journal of Thoracic and Cardiovascular Surg(n ¼ 2), pneumonia (n ¼ 2), hemothorax (n ¼ 1), and pul-
monary embolism (n ¼ 1).
DISCUSSION
The objectives of this study were 2-fold: to systemati-
cally quantify the burden of illness from PAAL using the
TM&M system and to stratify risk factors for nonsevere
PAAL (grades I and II) and severe PAAL (grades III, IV,
and V). We showed that as a whole, PAAL poses a burden
for patients and hospital resources by prolonging the me-
dian LOS by 4 days and increasing the rate of readmission
within 30 days by 20.4%. The Ottawa TM&M system
showed that the majority of PAAL cases are managed by
chest drains inserted at the time of surgery, and 90% of as-
sociated complications with PAAL are limited to pleural
and pulmonary complications, such as empyema and pneu-
monia. There is less association with complications in other
organ systems, such as cardiac, anastomotic, and wound,
which is similar to past studies.15,16
In the current study, we defined PAAL as the presence of
forced expiratory air leak on POD 5. However, it is clear
that there are other possibilities of defining PAAL. For ex-
ample, an air leak on POD 3 may be considered PAAL if
the patient underwent a single wedge resection only, be-
cause these patients are usually expected to be discharged
sooner than those who underwent lobectomy or extended
lobectomy. Nonetheless, given feedback from peers, in
keeping with the majority of prior reports, and in compli-
ance with Society of Thoracic Surgeons database, we elec-
ted to standardize the definition as air leak lasting greater
than 5 days from the operation.
Identifying patients at risk for PAAL and severe PAAL
helps design strategies to prevent these conditions. Of clin-
ical importance, we found that emphysema seen on preoper-
ative CT scan and obstructive pattern on PFTare significant
risk factors for severe PAAL. However, emphysema seen on
histopathology is not a significant risk factor. The CT and
histopathology findings of emphysema agree approximately
40% of the time, and more patients were found to have em-
physematous changes evident on histopathology. It is plau-
sible that mild emphysematous changes that could be seen
only under the microscope may not have as much impact
on the postoperative course as emphysematous changes vis-
ible on CT scan. Therefore, CT findings of emphysema and
obstructive pattern on PFT together can be used preopera-
tively to identify patients at risk for severe PAAL. The cur-
rent study was not able to use multivariate analysis to
identify predictors of severe PAAL because of the small
sample size (4.6% of all patients).We suggest future studies
to pool larger patient populations to properly perform such
an analysis. In addition, validation from independent co-
horts is necessary to evaluate reliability.
By delineating the risk factors and burden of illness, the
cost versus benefit of various intraoperative prevention andery c April 2013
FIGURE 1. Pie charts of types and grades of complications in control and PAAL groups. PAAL, Prolonged alveolar air leak.
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rately. Because the majority of PAAL cases are nonsevere in
nature and self-limited in time course (Table 4), these ex-
pensive measures may not be necessary for every patient.
However, they could benefit patients at risk for severe
PAAL, who are at risk for associated complications. Exam-
ples of intraoperative measures include the use of buttressed
stapled lines with bovine pericardium (Bio-Vascular Dry
Peri-Strips, Minneapolis, Minn), pleural tents for upper lo-
bectomy, pneumoperitoneum after lower lobectomy, focal
seal (Genzyme, Biosurgery, Cambridge, Mass), BioGlue
(CryoLife, Europa Ltd, Surrey, UK), collagen patch, and
so forth.19-21 These methods also have their drawbacks
other than cost and potential prolonged operative time.
Pleural tent can cause bleeding, and synthetic materials
may cause irritation and hypersensitivity. Although some
randomized trials showed a reduction of postoperative
arrhythmias, the meta-analysis by Malapert and col-
leagues19 did not find any reduction in atelectasis, hemo-
thorax, pneumonia, pneumothorax, and death by using
glue, patch, or buttress. Staple-line buttress, fibrin glue, syn-
thetic sealant, and collagen patch were not used in the cur-
rent study. We are engaged in further studies to determine
whether these intraoperative preventative measures could
decrease the incidence of severe PAAL.
In addition to intraoperative prevention methods, patients
who are at risk for severe PAAL should be closelyThe Journal of Thoracic and Camonitored and managed aggressively to prevent further
complications. Table 4 shows the importance of properly
managing severe PAAL because a significant portion of
these patients had PAAL for extended periods of time com-
pared with those with nonsevere PAAL. The postoperative
management of PAAL varies widely among institutions
and even between surgeons of the same institution. One
of the limitations of this study is that the amount of air
leak in the evacuation chambers was not recorded. We
hope that future studies will correlate the quantity of air
leak with the severity of PAAL by using the scale by Cerfo-
lio and colleagues.17 The optimal algorithm of suction and
water seal for the management of PAAL with analogue
chest drainage systems remains highly controversial. Sev-
eral randomized studies suggest the superiority of early wa-
ter seal instead of ongoing suction, with respect to
decreased days to resolution of air leak, LOS, and duration
of indwelling chest drain.17 Reduced suction can be
achieved by continuous low suction setting or alternating
‘‘on’’ at night and ‘‘off’’ during the day. However, larger
air leaks defined as bubbling greater than 4/7 by the scale
used by Cerfolio and colleagues17 may be better managed
by suction to treat pneumothorax and subcutaneous emphy-
sema. Past studies have shown that some form of reduced
suction was safe with close monitoring. Outpatient 1-way
valve chest drainage systems, such as the Heimlich or Pneu-
mostat valve (AtriumMedical Corp), also have been shownrdiovascular Surgery c Volume 145, Number 4 953
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Sto be safe and effective in asymptomatic patients with
a small stable pneumothorax.7 An idea for future work is
to randomize postoperative suction versus underwater seal
algorithms to determine whether either algorithm can re-
duce the incidence of severe PAAL.
Our data showed that the most notable complication in
the control group was cardiac complication in the form of
atrial fibrillation (rate of 40%). Despite the high prevalence
of atrial fibrillation in this group, the median LOS was rel-
atively short (median, 4 days, compared with 8 days in
PAAL), and fewer complications developed in patients
(0.42 per patient) compared with the PAAL group (1.26
per patient). It is unclear exactly why patients with PAAL
had a lower incidence of atrial fibrillation compared with
patients without PAAL. Past studies found that the risk fac-
tors for postoperative arrhythmias are mostly related to the
extent of pulmonary resection (especially pneumonec-
tomy), hilar manipulation, and preexisting heart disease.18
In the current study, there was no significant difference in
cardiac comorbidities between the groups, and the rates of
atrial fibrillation may be artificially low because all cases
of pneumonectomy were excluded.CONCLUSIONS
Our study stratified the risk factors predicting nonsevere
and severe PAAL after pulmonary resection by using the
Ottawa TM&M classification system. Findings of emphy-
sema on CT of the thorax along with an obstructive pattern
on PFT were significant predictors of severe PAAL. We
showed that the majority of PAAL cases in this series
were nonsevere in degree and managed with a single chest
tube inserted at the time of operation. In addition, patients
with PAAL were more likely to have additional postopera-
tive adverse events, and the majority of thesewere pleural or
pulmonary in nature (empyema and pneumonia). Future re-
search should focus on facilitating outpatient management
and hospital resource-savings for nonsevere PAAL cases.
With respect to severe PAAL, further investigation is needed
to examine the use of intraoperative preventative measures
in those at risk and the resultant postoperative rates.
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